Form 4: UnitedHealth Group Director Acquires Stock Units

John H. Noseworthy, a Director at UnitedHealth Group, acquired 206 deferred stock units as part of his regular quarterly compensation.

Summary

• John H. Noseworthy, a Director at UnitedHealth Group, acquired 206 deferred stock units on July 1, 2026.
• These units were granted as regular quarterly compensation for his service as a director.
• The deferred stock units are immediately vested but must be retained until completion of his service on the Board.
• Following this transaction, Noseworthy beneficially owns 7,616 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation and does not provide new financial performance data or strategic insights.

Positives

• Director compensation is being paid in equity, aligning director interests with shareholders.
• The acquisition of stock units by a director can signal confidence in the company's future performance.
• Deferred stock units are immediately vested, providing a form of immediate compensation for services rendered.

Negatives

• The filing does not disclose any negative financial or operational information.

Risks

• Deferred stock units must be retained until the director's completion of service, meaning the value is tied to the company's long-term performance and the director's tenure.
• Potential for insider selling in the future once the retention period for the deferred stock units expires.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a common practice in the healthcare and managed care industry, aiming to align executive and director interests with long-term shareholder value.

Comparison to Industry Standards

• The practice of granting deferred stock units as director compensation is standard across the healthcare and managed care sector, with companies like Anthem (now Elevance Health) and Cigna also utilizing similar equity-based incentive structures for their boards.

Stakeholder Impact

• Shareholders: The transaction aligns director interests with shareholders through equity ownership. The retention requirement ensures the director's commitment to long-term value.
• Employees: This filing does not directly impact employees.
• Creditors: This filing does not directly impact creditors.
• Suppliers: This filing does not directly impact suppliers.
• Customers: This filing does not directly impact customers.

Next Steps

• Director John H. Noseworthy will retain the deferred stock units until completion of his service on the Board.

Key Dates

Keywords

UnitedHealth Group, UNH, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, Equity Compensation, Beneficial Ownership